$21M Compounding Pharmacy Exposes Why Peptides are Trending | Ep. 407 with Kris Fishman CEO and President of Wells Pharmacy Network

About this episode

Daniel Robbins interviews Kris Fishman about the complexities of compounding pharmacies and the rise of peptides in personalized medicine.

Daniel Robbins sits down with Kris Fishman, CEO and President of Wells Pharmacy Network, to break down the confusing world of compounding pharmacies, peptides, GLP-1s, and personalized medicine. Kris explains why compounding exists, why peptides have exploded across social media, and how his company is navigating regulation, safety, speed, and demand. He also opens up about the sacrifices of leadership, missing much of his children’s lives while building, and why helping patients feel better became deeply personal for him.

People in this episode

Host: Daniel Robbins

Guest: Kris Fishman

Topics covered

• compounding pharmacies
• peptides
• personalized medicine
• leadership sacrifices
• healthcare regulation

Keywords

• compounding pharmacy
• peptides
• GLP-1
• personalized medicine
• healthcare regulation
• leadership
• patient care

Mentioned in this episode

Organizations: Wells Pharmacy Network

Products: peptides, GLP-1s

More episodes of Founder's Story

• Bootstrap or Raise VC? Here's the Math From a $150M Founder | Ep. 406 with Tal Lev-Ami Co-Founder and Chief Technology Officer at Cloudinary · June 10, 2026 · 29 min
• The Career Rule That Took Him From Bagger to 3-Time CIO | Ep. 405 with Harrison Allen Lewis Founding Partner at Jacob Meadow Associates · June 8, 2026 · 36 min
• Anastasia Soare Built a $3 Billion Empire. Started With No English. No Money. | Ep. 404 · June 2, 2026 · 42 min
• Spencer Pratt Wins LA Mayor and Other Shocking Predictions From Famous Psychic | Ep. 403 with Craig Hamilton-Parker · May 28, 2026 · 40 min
• Built a $34M Company on One Lesson From Her Dad at 7 | Ep. 401 with Kate Monroe · May 25, 2026 · 28 min
• AI Made MVPs Instant. So Why Are Most Startups Still Losing | Ep. 401 with Eric Ries · May 22, 2026 · 31 min